The association of XPG and MMS19L polymorphisms response to chemotherapy in osteosarcoma

The association of XPG and MMS19L polymorphisms response to chemotherapy in osteosarcoma

Objective: To assess the role of XPG, XPC, CCNH and MMS19L polymorphisms response to chemotherapy in osteosarcoma, and the clinical outcome of osteosarcoma.

Bibliographic Details
Main Authors: Zhao, Yi-lei, Yang, Li-bin, Geng, Xiao-lin, Zhou, Qing-lan, Qin, Hua, Yang, Lin, Dong, Yu-zhen, Zhong, Jin-Jie
Format: Online
Language:English
Published: Professional Medical Publicaitons 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858920/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858920/

Similar Items